Long/Short Equity, Short Only, Growth, Special Situations
Contributor Since 2010
Adam Gefvert is the head analyst for White Diamond Research, a research firm for hedge funds and high net worth individuals. You can read those reports at whitediamondresearch.com.
Primarily a short seller, he has saved investors millions of dollars by exposing highly overvalued small cap stocks. He has a 90%+ success rate with his Seeking Alpha short ideas. He specializes in technology, energy, and biotech stocks, because those are the sectors with the greatest valuation inefficiencies. You can follow Adam on twitter @shiningboy
Follow White Diamond Research on twitter @whiteresearch
AXON up 11% - Up on raised PT by Oppen. Says there's a larger opportunity for its main drug focusing on motor symptoms. Stock has reached a 52 week high, up a lot since they did the offering at $18.45 a few days ago.
AAOI up 11% - Beat on earnings, PT raised by several sell side analysts.
PLSE up 11% - Has found its range in the low $20s. It has been volatile but looks to be good here.
VRS up 10% - No news explaining why it's up.
AEHR up 10% - Likely up because of a higher than expected priced secondary offering.
LJPC up 10% - After a big slide from $35 on Mar 29th, down to $25 on Apr 12, on Apr 13, it finally bounced to $28 on a sellside analyst's upgrade.
IMGN up 9% - Up from sliding down the past week. No news.
SKYW up 9% - Up on RayJay ug to strong buy from op. This is because the stock has slid over 10% over the past couple of weeks, a value call by RayJay. Don't think it will go up much tomorrow since it just recovered from its slide.
MDXG up 8% - Up after reporting revenue will exceed high end of guidance.
SPU down 45% - Down so much because they did an offering of 2.7M shares, only 4.31 shares outstanding, at $3.10 per share. It fell slightly below that offering price.
DMPI down 25% - Down from a 20% discounted secondary offering. Sabby management took a 5.7% stake in the company from the offering. A nanocap biotech.
NADL down 21% - The deal with Conoco announced a few days ago sounds good, but the equity is still likely to become worthless as the stock goes bankrupt. The return on the deal wasn't immediate, and NADL has $2.3B in debt total.
DTEA down 17% - Bad earnings and guidance. CEO says 2017 will be a "reset year". That doesn't sound too good for investors. Closed almost at the lod, will likely fall more tomorrow.
FRSH down 14% - Down on negative press coverage.
GLBS down 13% - The stock has fell down into the $2s after being above $8 in February. The stock was trading at $8 even after it had announced the capital raise at below at an average of under $2 per share. It's market cap was almost $200M at the time, which shows how inefficient small cap and micro cap stocks are.
APOG down 13% - Company had record earnings results. But investors were disappointed at its slower growth forecast. With a PE of only 18, and no debt, it's surprising that the stock would be trading this low. But being at almost $2B market cap, experts know more about this company than I could know.
PIR down 9% - Had a bigger than expected loss. Forecast not great.
LXU down 9% - Down on slightly higher than average volume.